✦ LIBER ✦

Mito-FLAG as Salvage Therapy for Relapsed and Refractory Acute Myeloid Leukemia

✍ Scribed by Hänel, M. ;Friedrichsen, K. ;Hänel, A. ;Herbst, R. ;Morgner, A. ;Neser, S. ;Nicklisch, M. ;Teich, M. ;Ehninger, G. ;Fiedler, F.

Book ID: 121283808
Publisher: S. Karger AG
Year: 2001
Tongue: English
Weight: 87 KB
Volume: 24
Category: Article
ISSN: 2296-5270
DOI: 10.1159/000055107

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FLAG (fludarabine, cytosine arabinoside,

FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemia

✍ I.-M. Huhmann; H. H. Watzke; K. Geissler; H. Gisslinger; U. Jäger; P. Knöbl; I. 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 192 KB

Fludarabine and cytarabine in patients w

Fludarabine and cytarabine in patients with relapsed acute myeloid leukemia refractory to initial salvage therapy

✍ McLaughlin, Brian; Im, Annie; Raptis, Anastasios; Agha, Mounzer; Hou, Jing-Zhou; 📂 Article 📅 2012 🏛 Carden Jennings Publishing 🌐 English ⚖ 186 KB

Clofarabine combinations as acute myeloi

Clofarabine combinations as acute myeloid leukemia salvage therapy

✍ Stefan Faderl; Alessandra Ferrajoli; William Wierda; Xuelin Huang; Srdan Verstov 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Azacitidine as salvage therapy in elderl

Azacitidine as salvage therapy in elderly patients with relapsed acute myeloid leukemia after autologous transplantation

✍ Massimo Breccia, Adriano Salaroli, Alessandra Serrao… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 73 KB

Salvage therapy of refractory and relaps

Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine

✍ Pia Raanani; Ofer Shpilberg; Shmuel Gillis; Abraham Avigdor; Izhar Hardan; Miria 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Primary refractory and relapsed adult ac

Primary refractory and relapsed adult acute lymphoblastic leukemia : Characteristics, treatment results, and prognosis with salvage therapy

✍ Deborah A. Thomas; Hagop Kantarjian; Terry L. Smith; Charles Koller; Jorge Corte 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

## BACKGROUND. Relapses continue to be problematic for adults with acute lymphoblastic leukemia (ALL). New therapies generally are first tested in the salvage setting prior to incorporation into frontline regimens. Defining the prognosis at relapse (or at failure of induction) and subsequently pre